Non-Alcoholic Steatohepatitis (NASH) Pipeline Insight, 2024 Featuring 100+ Companies and 110+ Pipeline Drugs Including Lanifibranor (Inventiva Pharma), MSDC-0602K (Cirius Therapeutics), TERN-501 (Terns Pharma)
02. Mai 2024 07:25 ET
|
Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Research Report 20254: Patient Pool Analysis, Market Size and Market Forecasts 2020-2034
13. Februar 2024 09:50 ET
|
Research and Markets
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The "Nonalcoholic Steatohepatitis (NASH) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ...
Japan Non-Alcoholic Steatohepatitis (NASH) Market Forecast 2023-2032: Emerging Therapies & Treatment Insights, Comprehensive Market Outlook, Expert & Qualitative Analyses
30. Januar 2024 07:09 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Japan Non-Alcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast - 2032" report has been added to ...
Nonalcoholic Steatohepatitis Clinical Trial Pipeline Analysis of 100+ Companies | NASH Pipeline Report by DelveInsight
23. Mai 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 23, 2023 (GLOBE NEWSWIRE) -- Nonalcoholic Steatohepatitis Clinical Trial Pipeline Analysis of 100+ Companies | NASH Pipeline Report by DelveInsight Nonalcoholic steatohepatitis...
Nonalcoholic Steatohepatitis Drug Pipeline Analysis Review, 2020
13. Januar 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, USA , Jan. 13, 2021 (GLOBE NEWSWIRE) -- Nonalcoholic Steatohepatitis Drug Pipeline Analysis Review, 2020 NASH Drug Pipeline Shows Promise as 95+ companies are working for...